Does the magnitude of improvement of UPDRS III at the preoperative L-dopa test predict the degree of medication decrease one year after subthalamic nucleus Deep Brain Stimulation?
Objective: To investigate whether the magnitude of improvement in motor scores of the Unified Parkinson´s Disease Rating Scale (UPDRS III) at the preoperative L-dopa challenge…Beneficial effect of 36-month bilateral subthalamic stimulation on quality of sleep compared to standard-of-care medication in Parkinson’s disease
Objective: To examine 36-month effects of bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) on quality of sleep, depression, and quality of life (QoL) compared…Optimized Imaging at 3.0 T of the Rostral Zona Incerta (rZI) for Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD)
Objective: To improve upon imaging of the rostral zona incerta (rZI) allowing for direct targeting during deep brain stimulation. Background: DBS of the subthalamic nucleus…Higher motor cortex connectivity with subthalamic stimulation than with levodopa: A resting state fMRI study in Parkinson’s disease
Objective: To perform a direct comparison between the effect of levodopa medication and deep brain stimulation of the subthalamic nucleus (STN DBS) on functional brain…Comparison of Mattis and MOCA testing for neuropsychological assessment in the preoperative evaluation of subthalamic nucleus stimulation in Parkinson´s disease
Objective: The aim of the current study is to evaluate, whether 1. MOCA (Montreal Cognitive Assessment) and Mattis tests are equivalent in the detection of…Long-term and dopamine dependent dynamics of subthalamic nucleus local field potentials in Parkinson’s disease
Objective: Using a new deep brain stimulation (DBS) pulse generator device that can record local field potentials (Activa PC+S, Medtronic Inc.), the current experiment investigated…Weight loss in STN DBS in Parkinson’s Disease? Long-term outcome of a prospective cohort at 5 years
Objective: To determine the long-term weight changes in Parkinson’s Disease (PD) after Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) treatment. Background: It is well-established that…Optimization of deep brain stimulation in STN among patients with Parkinson’s disease using a novel EEG-based tool
Objective: The current study aims to develop an innovative method for objective differentiation between the locations of the four DBS contacts in the various parts…Long Term Outcome of the Subthalamic Nucleus DBS for Advanced Parkinson’s Disease: An Eight Years Follow-Up Study in China
Objective: To investigate the long term efficacy and its safety of STN DBS for PD in China with an eight years follow up of ten…Cerebrospinal fluid protein biomarkers in PD patients after DBS-STN surgery: A retrospective analysis of patients that underwent surgery between 1993 and 2001
Objective: To investigate cerebrospinal fluid (CSF) markers of neurodegeneration [neurofilament light chain (NFL), total Tau (T-Tau)], tau pathology [phosphorylated tau (p-Tau)], glial cell damage or…
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 33
- Next Page »